Healthcare provider profile · identity verified

Terry Lee Pieper, MD

Internal Medicine · SOUTHPORT, NC · NPI 1255308516

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	514	141
Levothyroxine Sodium	Levothyroxine Sodium	368	99
Rosuvastatin Calcium	Rosuvastatin Calcium	290	74
Amlodipine Besylate	Amlodipine Besylate	278	67
Lisinopril	Lisinopril	194	52
Gabapentin	Gabapentin	185	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	167	19
Metoprolol Succinate	Metoprolol Succinate	163	49
Omeprazole	Omeprazole	156	51
Zolpidem Tartrate	Zolpidem Tartrate	155	41
Furosemide	Furosemide	151	46
Pantoprazole Sodium	Pantoprazole Sodium	144	40
Alprazolam	Alprazolam	137	35
Prednisone	Prednisone	123	74
Escitalopram Oxalate	Escitalopram Oxalate	122	32
Metformin Hcl	Metformin Hcl	121	32
Hydrochlorothiazide	Hydrochlorothiazide	117	38
Losartan Potassium	Losartan Potassium	117	32
Tamsulosin Hcl	Tamsulosin Hcl	117	32
Allopurinol	Allopurinol	109	24
Sertraline Hcl	Sertraline Hcl	106	26
Tramadol Hcl	Tramadol Hcl	104	22
Fluticasone Propionate	Fluticasone Propionate	97	40
Pravastatin Sodium	Pravastatin Sodium	95	25
Glimepiride	Glimepiride	94	26
Eliquis	Apixaban	89	22
Clopidogrel	Clopidogrel Bisulfate	83	20
Simvastatin	Simvastatin	83	26
Donepezil Hcl	Donepezil Hcl	82	17
Trazodone Hcl	Trazodone Hcl	77	23
Potassium Chloride	Potassium Chloride	75	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	20
Lorazepam	Lorazepam	66	16
Atenolol	Atenolol	64	16
Ezetimibe	Ezetimibe	63	19
Duloxetine Hcl	Duloxetine Hcl	62	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	21
Meloxicam	Meloxicam	62	21
Metoprolol Tartrate	Metoprolol Tartrate	61	18
Synthroid	Levothyroxine Sodium	60	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	14
Finasteride	Finasteride	53	12
Ozempic	Semaglutide	53	13
Citalopram Hbr	Citalopram Hydrobromide	52	11
Xarelto	Rivaroxaban	52	11
Lamotrigine	Lamotrigine	51	suppressed
Montelukast Sodium	Montelukast Sodium	51	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	50	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	50	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	29
Carvedilol	Carvedilol	48	12
Oxycodone Hcl	Oxycodone Hcl	48	suppressed
Valsartan	Valsartan	47	13
Azithromycin	Azithromycin	46	39
Albuterol Sulfate Hfa	Albuterol Sulfate	45	22
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	35
Amoxicillin	Amoxicillin	42	37
Clonazepam	Clonazepam	42	suppressed
Diazepam	Diazepam	42	18
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Spironolactone	Spironolactone	39	12
Ramipril	Ramipril	38	suppressed
Lovastatin	Lovastatin	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Temazepam	Temazepam	35	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	16
Clonidine Hcl	Clonidine Hcl	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	12
Buspirone Hcl	Buspirone Hcl	25	suppressed
Famotidine	Famotidine	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	14
Glipizide	Glipizide	23	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Warfarin Sodium	Warfarin Sodium	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Risperidone	Risperidone	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Bumetanide	Bumetanide	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Cephalexin	Cephalexin	14	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nystatin	Nystatin	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error